URQ-14785-62039 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-17
Dose 1 — Pfizer-BioNTech
2021-05-13
Dose 2 — Pfizer-BioNTech
2021-05-14
Registered in v-safe
2021-05-14
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-05-15
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness

Adult check-in
2021-05-16
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2021-05-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-05-20
Health check-in — day 7, dose 2
Feeling: Fair · Fatigue or tiredness

Adult check-in
2021-05-27
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-08-12
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-11-11
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2021-12-13
Dose 3 — Pfizer-BioNTech
2022-09-30
Dose 4 — Pfizer-BioNTech
2022-10-16
Health check-in — day 14, dose 4
Feeling: Good

Adult check-in
2022-10-21
Health check-in — day 21, dose 4
Feeling: Good

Adult check-in
2022-10-28
Health check-in — day 28, dose 4
Feeling: Good

Adult check-in
2022-11-06
Health check-in — day 35, dose 4
Feeling: Good

Adult check-in
2022-12-30
Survey response — 3 months, dose 4
MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Covid-19

MedDRA releases: 2024-11 · check-in free text available
2022-12-30
Report sent to call center — 3 months, dose 4
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · 1 call case(s)
2023-01-03
Call 1 — Left Voicemail
2023-04-02
Health check-in — 6 months, dose 4
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-17	Pfizer-BioNTech
2	2021-05-13	Pfizer-BioNTech
3	2021-12-13	Pfizer-BioNTech	No
4	2022-09-30	Pfizer-BioNTech	No

Call center

Reported	Outcome	VAERS-related outcome
2022-12-30	Unsuccessful

Free text

Release 12 — 3 months, dose 4

2022-12-30

Symptoms: Covid-19

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release